Pfizer struck a deal with the Trump administration to lower its U.S. medicine prices and invest an additional $70 billion in onshore manufacturing in exchange for shelter from tariffs.
Pfizer Reaches Agreement with Trump Administration to Lower Drug Costs in U.S., Invest $70B — Update
view original post